No heart benefit seen with fibrates [Tricor] in diabetics (reuters)
SJCRG: In a nutshell, study purports that a class of drugs called fenofibrates, who aim to to lower the blood fat triglycerides and raise good HDL cholesterol, are of little benefit. TriCor, from Abbots labs belongs to such.
Study conclusions do not seem iron clad, but raises a flag. click HERE for Reuters article.
SJRG: FDA current position on this:
“…At this time, FDA has made no new conclusions or recommendations regarding the combination use of simvastatin or other statin drugs and fenofibrate. The agency will conduct a thorough review of the primary ACCORD data as soon as they become available….” click HERE for FDA position
Categories: CHF, Diabetes, Good Cholestreol, HDL, Heart Failure, High Blood Pressure, Triglycerides, heart disease Tags: benefit, CareResourceGuide, diabetics, fibrates, heart, no, reuters, sjcrg
